Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. En savoir plus sur Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices. En savoir plus sur Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. En savoir plus sur Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.
Risk factors and prognostic impact of left ventricular assist device-associated infections. En savoir plus sur Risk factors and prognostic impact of left ventricular assist device-associated infections.
Incidence predictors and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study. En savoir plus sur Incidence predictors and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.
Early Ventricular Arrhythmias After LVAD Implantation Is the Strongest Predictor of 30-Day Post-Operative Mortality. En savoir plus sur Early Ventricular Arrhythmias After LVAD Implantation Is the Strongest Predictor of 30-Day Post-Operative Mortality.
Current results of left ventricular assist device therapy in France: the ASSIST-ICD registry. En savoir plus sur Current results of left ventricular assist device therapy in France: the ASSIST-ICD registry.